Professor Andrew S Rice

Publications


Journals

  • Phillips TJ; Cherry CL; Cox S; Marshall SJ; Rice AS. (2010). Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials. PLoS One. 5:e14433. DOI.
  • White JP; Cibelli M; Fidalgo AR; Paule CC; Anderson PJ; Jenes A; Rice AS; Nagy I. (17 Mar 2010). Sensitization of the transient receptor potential vanilloid type 1 ion channel by isoflurane or sevoflurane does not result in extracellular signal-regulated kinase 1/2 activation in rat spinal dorsal horn neurons. Neuroscience. 166:633-638. DOI.
  • Legg ED; Novejarque A; Rice AS. (Jul 2009). The Three Ages of Rat: the influence of rodent age on affective and cognitive outcome measures in peripheral neuropathic pain. Pain. 144:12-13. DOI.
  • Lever IJ; Robinson M; Cibelli M; Paule C; Santha P; Yee L; Hunt SP; Cravatt BF; et alElphick MR; Nagy I; Rice AS. (25 Mar 2009). Localization of the endocannabinoid-degrading enzyme fatty acid amide hydrolase in rat dorsal root ganglion cells and its regulation after peripheral nerve injury. J Neurosci. 29:3766-3780. DOI.
  • Rice AS. (Dec 2008). Should cannabinoids be used as analgesics for neuropathic pain?. Nat Clin Pract Neurol. 4:654-655. DOI.
  • Wallace VC; Segerdahl AR; Blackbeard J; Pheby T; Rice AS. (19 Dec 2008). Anxiety-like behaviour is attenuated by gabapentin, morphine and diazepam in a rodent model of HIV anti-retroviral-associated neuropathic pain. Neurosci Lett. 448:153-156. DOI.
  • Rice AS; Cimino-Brown D; Eisenach JC; Kontinen VK; Lacroix-Fralish ML; Machin I; Preclinical Pain Consortium; Mogil JS; et alStöhr T. (15 Oct 2008). Animal models and the prediction of efficacy in clinical trials of analgesic drugs: a critical appraisal and call for uniform reporting standards. Pain. 139:243-247. DOI.
  • Maratou K; Wallace VC; Hasnie FS; Okuse K; Hosseini R; Jina N; Blackbeard J; Pheby T; et alOrengo C; Dickenson AH; McMahon SB; Rice AS. (Apr 2009). Comparison of dorsal root ganglion gene expression in rat models of traumatic and HIV-associated neuropathic pain. Eur J Pain. 13:387-398. DOI.
  • Daniel HC; Narewska J; Serpell M; Hoggart B; Johnson R; Rice AS. (Aug 2008). Comparison of psychological and physical function in neuropathic pain and nociceptive pain: implications for cognitive behavioral pain management programs. Eur J Pain. 12:731-741. DOI.
  • Wallace VC; Blackbeard J; Segerdahl AR; Hasnie F; Pheby T; McMahon SB; Rice AS. (Oct 2007). Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain. Brain. 130:2688-2702. DOI.
  • Blackbeard J; O'Dea KP; Wallace VC; Segerdahl A; Pheby T; Takata M; Field MJ; Rice AS. (30 Aug 2007). Quantification of the rat spinal microglial response to peripheral nerve injury as revealed by immunohistochemical image analysis and flow cytometry. J Neurosci Methods. 164:207-217. DOI.
  • Wallace VC; Segerdahl AR; Lambert DM; Vandevoorde S; Blackbeard J; Pheby T; Hasnie F; Rice AS. (Aug 2007). The effect of the palmitoylethanolamide analogue, palmitoylallylamide (L-29) on pain behaviour in rodent models of neuropathy. Br J Pharmacol. 151:1117-1128. DOI.
  • Hasnie FS; Wallace VC; Hefner K; Holmes A; Rice AS. (Jun 2007). Mechanical and cold hypersensitivity in nerve-injured C57BL/6J mice is not associated with fear-avoidance- and depression-related behaviour. Br J Anaesth. 98:816-822. DOI.
  • Lever IJ; Pheby TM; Rice AS. (May 2007). Continuous infusion of the cannabinoid WIN 55,212-2 to the site of a peripheral nerve injury reduces mechanical and cold hypersensitivity. Br J Pharmacol. 151:292-302. DOI.
  • Wallace VC; Blackbeard J; Pheby T; Segerdahl AR; Davies M; Hasnie F; Hall S; McMahon SB; et alRice AS. (15 Dec 2007). Pharmacological, behavioural and mechanistic analysis of HIV-1 gp120 induced painful neuropathy. Pain. 133:47-63. DOI.
  • Hasnie FS; Breuer J; Parker S; Wallace V; Blackbeard J; Lever I; Kinchington PR; Dickenson AH; et alPheby T; Rice AS. (23 Feb 2007). Further characterization of a rat model of varicella zoster virus-associated pain: Relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic drugs. Neuroscience. 144:1495-1508. DOI.
  • Lever IJ; Rice AS. (2007). Cannabinoids and pain. Handb Exp Pharmacol. 265-306.
  • Rice AS; Hill RG. (2006). New treatments for neuropathic pain. Annu Rev Med. 57:535-551. DOI.
  • Wallace VC; Norbury TA; Rice AS. (Aug 2005). Ultrasound vocalisation by rodents does not correlate with behavioural measures of persistent pain. Eur J Pain. 9:445-452. DOI.
  • Hempenstall, K; Nurmikko, TJ; Johnson, RW; A Hern, RP; Rice, ASC. (2005). Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. Public Library of Science Medicine. 7, 2:628-644. Author weblink.
  • Brooks JW; Thompson SW; Rice AS; Malcangio M. (30 Nov 2004). (S)-AMPA inhibits electrically evoked calcitonin gene-related peptide (CGRP) release from the rat dorsal horn: reversal by cannabinoid receptor antagonist SR141716A. Neurosci Lett. 372:85-88. DOI.
  • Sabatoswki, R; Galvez, R; Cherry D.A; Jacquot, F; Vincent, E; Maisonobe, P; Versavel, M; The 1008-045 Study Group including Rice, A.S.C. (2004). Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised placebo controlled clinical trial. Pain. 1-2, 109:26-35.
  • Farquhar-Smith WP; Rice AS. (Dec 2003). A novel neuroimmune mechanism in cannabinoid-mediated attenuation of nerve growth factor-induced hyperalgesia. Anesthesiology. 99:1391-1401.
  • Bridges D; Rice AS; Egertová M; Elphick MR; Winter J; Michael GJ. (2003). Localisation of cannabinoid receptor 1 in rat dorsal root ganglion using in situ hybridisation and immunohistochemistry. Neuroscience. 119:803-812.
  • Beaulieu P; Rice AS. (Jun 2002). [The pharmacology of cannabinoid derivatives: are there applications to treatment of pain?]. Ann Fr Anesth Reanim. 21:493-508.
  • Farquhar-Smith WP; Jaggar SI; Rice AS. (May 2002). Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors. Pain. 97:11-21.
  • Brooks JW; Pryce G; Bisogno T; Jaggar SI; Hankey DJ; Brown P; Bridges D; Ledent C; et alBifulco M; Rice AS; Di Marzo V; Baker D. (29 Mar 2002). Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB(1)/CB(2) receptors. Eur J Pharmacol. 439:83-92.
  • Hempenstall K; Rice AS. (Mar 2002). Current treatment options in neuropathic pain. Curr Opin Investig Drugs. 3:441-448.
  • Rice AS; Farquhar-Smith WP; Nagy I. (Feb 2002). Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy. Prostaglandins Leukot Essent Fatty Acids. 66:243-256. DOI.
  • Melck D; Bisogno T; De Petrocellis L; Beaulieu P; Rice AS; Di Marzo V. (2002). Cannabimimetic eicosanoids in cancer and inflammation: an update. Adv Exp Med Biol. 507:381-386.
  • Rice AS; Maton S; Postherpetic Neuralgia Study Group. (Nov 2001). Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain. 94:215-224.
  • Bridges D; Thompson SW; Rice AS. (Jul 2001). Mechanisms of neuropathic pain. Br J Anaesth. 87:12-26.
  • Bridges D; Ahmad K; Rice AS. (Jun 2001). The synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain. Br J Pharmacol. 133:586-594. DOI.
  • Farquhar-Smith WP; Rice AS. (Mar 2001). Administration of endocannabinoids prevents a referred hyperalgesia associated with inflammation of the urinary bladder. Anesthesiology. 94:507-513.
  • Rice AS. (Mar 2001). Cannabinoids and pain. Curr Opin Investig Drugs. 2:399-414.
  • Jaggar SI; Scott HC; James IF; Rice AS. (Jan 2001). The capsaicin analogue SDZ249-665 attenuates the hyper-reflexia and referred hyperalgesia associated with inflammation of the rat urinary bladder. Pain. 89:229-235.
  • Farquhar-Smith WP; Egertová M; Bradbury EJ; McMahon SB; Rice AS; Elphick MR. (Jun 2000). Cannabinoid CB(1) receptor expression in rat spinal cord. Mol Cell Neurosci. 15:510-521. DOI.
  • Beaulieu1 P; Bisogno1 T; Punwar S; Farquhar-Smith WP; Ambrosino G; Di Marzo V; Rice AS. (19 May 2000). Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat. Eur J Pharmacol. 396:85-92.
  • Jaggar SI; Scott HC; Rice AS. (Sep 1999). Inflammation of the rat urinary bladder is associated with a referred thermal hyperalgesia which is nerve growth factor dependent. Br J Anaesth. 83:442-448.
  • Jaggar SI; Sellaturay S; Rice AS. (4 Sep 1998). The endogenous cannabinoid anandamide, but not the CB2 ligand palmitoylethanolamide, prevents the viscero-visceral hyper-reflexia associated with inflammation of the rat urinary bladder. Neurosci Lett. 253:123-126.
  • Jaggar SI; Hasnie FS; Sellaturay S; Rice AS. (May 1998). The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. Pain. 76:189-199.
  • Jaggar SI; Habib S; Rice AS. (Apr 1998). The modulatory effects of bradykinin B1 and B2 receptor antagonists upon viscero-visceral hyper-reflexia in a rat model of visceral hyperalgesia. Pain. 75:169-176.
  • Jaggar, S.I; Sellaturay, S; Hasnie, F.S. (1998). The anti-hyperalgesic action of the cannabinoid agaonist anandamide and the putative CB2 agonist palmitoylethanoladmide in 2 animal models of inflammatory pain. Pain. 76:189-199.
  • Dimitrieva, N; Shelton, D; Rice, A.S.C. (1997). The role of nerve growth factor in a model of visceral inflammation. Neuroscience. 78:449-459.
  • Parke, J; Miller, S; Old, S; Goodwin, A.P. (1995). Ketorolac for early postoperative analgesia. J Clinical Anesthesia. 7:465-469.
  • Rice, A.S.C; Whitehead, E.M; O'Sullivan, G; Lloyd, J. (1995). Speed of onset of analgesic effect of intravenous ketorolac compared to morphine and placebo. Eur J Anaesthesiol. 12:313-317.
  • Rice, A.S.C; Andreev, N. (1995). The consequences of microneurography electrode induced injury of peripheral nerves observed in the rat and man. Pain and Yearbook of Pain.
  • Rice, A.S.C. (1994). Pre-emptive intrathecal administration of an NMDA receptor antagonist (APS) prevents hyper-reflexia in a model of persistent visceral pain. Pain. 57:335-340.
  • Rice, A.S.C; Lloyd, J; Bullingham, R. (1993). Ketorolac penetration into the cerebrospinal fluid of humans. J Clinical Anesthesia. 5:459-462.
  • Rice, A.S.C; McMahon, S.B. (1993). The electrophysiological consequences of electrode impalement of peripheral nerves in the rat. Brain Research. 631:221-226.
  • Rice, A.S.C; O'Sullivan, G; Bullingham, R; Lloyd, J. (1992). A double blind study of the speed of onset of analgesia following intramuscular administration of ketorolac, in comparision to morphine and placebo. Anaesthesia. 39.
  • Parke, J.J; Stevens, J.F; Rice, A.S.C; Greenaway, C.L; Bray, R.J; Smith, P.J; Waldmann, C.S. (1992). Metabolic acidosis and fatal myocardial failure after propofol infusion in children. British Medical Journal. 305:613-616.
  • Rice, A.S.C. (1992). Peripheral nerve injury caused by injection needle used in regional anaesthesia: the influence of bevel configuration, studied in a rat model. British Journal of Anaesthesia. 69:433-438.
  • Rice, A.S.C; Pither, C.E. (1991). Plasma concentrations of bupivacaine after supraclavicular brachial plexus blockade in patients with chronic renal failure. Anaesthesia. 46:354-357.
  • Rice, A.S.C. (1987). Comparison of trichloroethylene and enflurane as adiunets to nitrous oxide and relaxant anaesthesia. Anaesthesia. 42:1320-1323.
  • Rice, A.S.C. Topical spinal administration of a nitric oxide synthase inhibitor prevents the hyper-reflexia associated with a rat model of persistent visceral pain. Neuroscience Letters. 187:111.

Books

  • Campbell W; Breivik H; Nicholas MK; Newton-John T. Rice ASC (ed); Justins D (ed); Newton-John T (ed); Howard RF (ed); Miaskowski CA (ed). Clinical Pain Management Practice and Procedures. 2, 4. Hodder, London (15 Nov 2008). Publisher weblink.
  • Sykes N; Bennet M; Yuan C. Rice ASC (ed); Justins D (ed); Newton-John T (ed); Howard RF (ed); Miaskoski CA (ed). Clinical Pain Management Cancer Pain. 2, 3. Hodder, London (15 Nov 2008). Publisher weblink.
  • Wilson P; Jensen T; Watson P; Haythornthwaite JA. Rice ASC (ed); Justins D (ed); Newton-John T (ed); Howard RF (ed); Miakowski CA (ed). Clinical Pain Management Chronic Pain. 2, 2. Hodder, London (29 Nov 2008). Publisher weblink.
  • Macintyre P; Rowbotham D; Walker S. Rice ASC (ed); Justins D (ed); Newton-John T (ed); Howard RF (ed); Miaskowski CA (ed). Clinical Pain Management Acute Pain. 2, 1. Hodder, London (26 Sep 2008). Publisher weblink.
  • Rice AS. Rice (ed); Warfield (ed); Justins (ed); Eccleston (ed). Textbook of Clinical pain Managment. Arnold, London (2003).

Chapters in books

  • Lever, I. Cannabinoids. In Handbook of Experimental Pharmacology analgesia. Stein C (ed). Springer, Berlin (2006).
  • Hill, R. New treatments for neuropathic pain. In Annual Review of Medicine. 57:535-551. (2006).
  • Rice, A.S.C. Cannabinoids. In Melzack and Wall's Textbook of Pain. 5th. McMahon SB (ed); Koltzenburg M (ed). Elsvier, Amsterdam (2005).
  • Marshall, S.J; Cox, S. Pain in HIV and Aids. In Handbook of Pain Management. 3rd:446-462. Ballantyne J (ed). Lippincott, Williams and Wilkins, Philadelphia (2005).
  • Rice, A.S.C. Analgesics: cannabinoids. In Anesthetic Pharmacology: Physiologic Principles and Clinical Practice. 491-506. Evers A (ed); Maze M (ed). Harcourt Health Sciences, St Louis (2003).
  • Rice, A.S.C; Farquhar-Smith, W.P; Bridges, D. Cannabinoids anad Pain Proceedings of the 10th World Congress on Pain. In Progress in Pain Control and Management. 24:437-467. Dostrovsky (ed); Carr JO (ed); H D (ed); Kolztenburg (ed); M (ed). IASB Press, Seattle (2003).
  • Rice, A.S.C. Local Neuroimmune interactions in visceral hyperalgesia. Bradykinin neutrophins and cannabinoids. In Pain: Current understanding, emerging therapies and novel approaches to drug discovery. 135-148. Bountra (ed); C (ed); Munglani R (ed); Schmid (ed); V K (ed). Marcel Dekker, New York (2003).
  • Melck, D; Bisogno, T; De Petrocellis, L; Beaulieu, P; Rice, A.S.C. Cannabimmetric eicosanoids in cancer and inflammation: an update. In Adv Exp Biol Med. Eicosanids and Other bioactive Lipids in Cancer Inflammation and Radiation Injuryry. 507:381-386. (2002).
  • Hempenstall, K. Current treatment opinions in neuropathic pain. In Current Opinion in Investigational Drugs. 3, 3:441-448. (2002).
  • Rice, A.S.C; Farquhar-Smith, W.P. Endocannabinoids and Pain Spinal and Peripheral Analgesia in Inflammation and Neuropathy. In Prostaglandins Leukotrienes and Essential Fatty Acids. 66, 2-3:243-256. (2002).
  • Rice AS. Mechanisms of Inflammatory Pain: Role of neurotrophins and cannabinoids. 35-45. (2002).
  • Rice, A.S.C. Pharmacologie des derives cannabinoides: applications au raitement de la douleur?. In Ann Fr Anesth Reanim. 21, 6:493-508. (2002).
  • Rice, A.S.C. Cannabinoids and pain. In Current Opinion In Investigational Drugs. 2, 3:399-414. (2001).
  • Bridges, D; Thompson, S.W.N. Mechanisms of neuropathic pain. In British Journal of Anaesthesia. 87, 1:12-26. (2001).
  • Anonymous (see Drugs and Therapeutics, Bulletin. Drug Treatment of Neuropathic Pain. In Drugs and Therapies Bulletin. 38, 12:89-93. (2000).
  • Rice, A.S.C. Pain mechanisms and pathways. In Current Anaesthesia and Critical Care. 10:98-104. (1999).
  • Rice, A.S.C. Developments in the pathophysiology of acute pain. In Acute pain. 1, 2:27-36. (1998).
  • Lachmann, P.J; Edwards, J.G; Pertwee, R.G; Robbins, I.W; Sykes, Sir R; Wall, P.D. The use of cannabis and its derivatives for medical and recreational purposes. In The Royal Society and the Academy of Medical Sciences. (1998).
  • Rice, A.S.C. Prevention of nerve damage in branchial plexus block. In Highights in Pain and Regional Anaesthesia. VI:60-64. Zundert AV (ed). Permanver Publications (1997).
  • Jaggar, S.I. Novel vistas in analgesic pharmacology for the treatment of chronic pain. In Anaesthetic Pharmacology and Physiology Review. 4:66-73. (1996).
  • Rice, A.S.C. The relative effects of analgesic therapy given beofore during or after surgery. In Seminars in the Neurosciences. 7:245-251. (1995).
  • Rice, A.S.C. Microneurography and the investigation of pain mechanisms. In Pain Reviews. 1:123-139. (1994).
  • Holdcroft, A; Hargreaves, K; Rice, A.S.C. Cannabinoids and pain modulation in animals and humans. In Proceedings of the 10th World Congree of Pain. Progess in Pain Research and Management. 915-926. Devor (ed); Rowbothan M (ed); M (ed); Wiesenfeld HZ (ed). IASP Press, Seattle.
  • Rice, A.S.C. Mechanisms of Inflammatory Pain: Role of neutrophins and cannabinoids. In Pain: Nature and management in man and animals. International Congress and Symposium Series, 246:35-45. Soulsby L (ed); Morton (ed); D (ed). Royal Society of Medicine Press, London.
  • Farquhar-Smith, W.P. Peripheral mechanisms of inflammatory pain towards the discovery of novel analgesics. In Recent Advances in Anaesthesia and Analgesia. 41-60. Adams AP (ed); Cashman JN (ed). Churchill Livingstone.
  • Faruqhar-Smith, W.P. Pharmacological control of neuropathic pain. In The Prescriber. 19 March:98-109.
  • Rice, A.S.C. The pathophysiology of acute pain. In Highlights in Pain and Regional Anaesthesia. VI:244-248. Zundert AV (ed). Permanver Publications.

Conferences

  • Hietaharju AJ; Lasry-Levy E; Pai VV; Ganapati R; Rice AS; Haanpaa M; Lockwood DN. Prevalence of neuropathic pain in patients with treated leprosy. 19th World Congress of Neurology, 24 Oct 2009 - 30 Oct 2009. 285:S318-S318. ELSEVIER SCIENCE BV (1 Oct 2009). Author weblink.

Patents

  • Application: ICOY/P28435GB.
  • Methods to Relieve Pain. Patent number: WO079771. Awarded: 2005.
Share this on Delicious
Tweet this
Digg this
Stumble this
Share this on Facebook